Member Info for Kashdog

Rats, I am a full blooded supporter of SCLP. I have never attempted to deramp, at least not intentionally, if you check my posts, you will note that I make the effort to give the opinion “strong buy” at all times...so do one!!

Dunno!... is it?

Market pre-empting the presentation?...already aware of content if pre-recorded possibly?..who knows!

Violindog, It might be Merck..they "canned" their vaccine but I would suggest that they would like to be "connected" to a successful 2nd gen vaccine given the potential returns

I had not realised it was for any tumour expressing the antigen....others may have!

"The Company's products include SCIB1, SCIB2 and Modi-1. The Company's first cancer vaccine, SCIB1, is being developed for the treatment of melanoma and is in Phase I/II clinical trials. SCIB2 contains multiple T cell epitopes derived from the lung cancer associated antigen NY-ESO-1. It is developed to the point at which the product is defined and ready for further preclinical development as an immunotherapy for any tumor that expresses the NY-ESO-1 antigen. The Company's first Moditope development candidate is Modi-1. Modi-1 consists of two citrullinated vimentin peptides and one citrullinated enolase peptide."

I think it might be Merck.... due to the Redmile connection but it is all guesswork!

FOMO! Hopefully tomorrow :-D

Redmile is an American Company ain't it?... just saying!... cuz I 'm wondering why the pandemic should be reliant on a uk backed solution...It's a global issue innit?... requiring a globally supported solution?.....aka Scancell! :-) :-)

NYpost?.. reinforces an American connection!...Redmile motivated?... love it? :-)

Mon/Tue/Wed... north of 23.... resistance at 25 until progress on development / progress news!

The big pharma partner could be Merck... given Redmile's involvement with both Merck and Scancell.....just saying!!

DYOR......lazy Bunnie!...:-)

Twelve months ago this month, Merck announced that they were "spinning off" three divisions to focus on Oncology and Vaccines. Four months later (June 2020) Redmile sold off their investment in Bristol Myers Squibb and bought into Merck. Five months later (Oct / Nov 2020), Redmile invested in Scancell....anyone else connecting the dots or is it just me in speculative mode?

My trade at 10.43 is showing as a "sell" when it was a "buy"....???

C7, "Tick up", "Bid rising" "Full ask paid" etc, etc, ad nauseum!! Give it a rest please, we don't need the tedious running commentary!
Your focus is entirely financial, not sure you care much about anything else...go ahead and delete this, as you do most of my posts on my observations on your behaviour!

Scancell shareholders need to ignore the deployed Chaff and stay mission focussed because the targets are in the open here.
Product development and monetisation need to push forward!.. we will win with this.

Wild, I agree and Rats has offered up some good questions that could lead to different takes on the RNS.
I have the view that having back the product means that if it is further developed successfully then we take all of the pie!!.

Ok!... my work here is done!!.... it's been a blast!...Good Luck with that RNS...Bye!! :-D

Mr. Investment...that's an ironic name you've given yourself seeing as you appear to have invested in UKOG, Wishbone and here!!
You think I am trying to manipulate the market...I wished a had that capability but thanks for the backhanded compliment :-)
I am not invested here and will not be investing here. I genuinely hope that the PI's including you don't get burnt. To say I don't have a clue!....well let's wait and see!...if the information I have posted here turns out to be wrong then that should be good for you and of no matter to me.

Good question Ismalia, probable answer is a few days as the well has not kicked in so I would expect that the Operator and UJO are considering some form of stimulation (i will avoid using the word fracking for obvious reasons :-)...)